An RCT was not valid anymore as app has become open source and will risk a contamination of study population
Effectiveness of Cognitive Behavioral Therapy for Insomnia in Young Adults With Chronic Pain
YAC
Evaluating the Effectiveness of Cognitive Behavioral Therapy for Insomnia on Patient Centered Outcomes Such as Self Efficacy, Pain Control and Overall Quality of Life in the Young Adult Chronic Pain Population: The Young Adult CBTi (YAC)
The aim of the Young Adult Cognitive Behavioral Therapy (YAC) study is to evaluate the effectiveness of the Delivering Online "ZZZ's with Empirical support (DOZE) app, a unique digital cognitive behavioral therapy for insomnia (CBTi) in young adult patients with chronic pain.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
withdrawn
Actual enrollment (reported)
0 participants
Study completion date
August 10, 2021
Actual (reported)
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Number of Participants recruited/dropping out of study (accrual/dropout rates)
1 year
Study compliance to DOZE app intervention/Sleep diary
Number of Participants completing/using the DOZE app and completing the sleep diary during 10 weeks study intervention
10 weeks
Study DOZE app treatment evaluation
Participants' scoring on a 5 point Likert scale pre and post study intervention
12 weeks
Secondary Outcomes (3)
Patient reported improvement in sleep & pain
12 weeks
Patient reported improvement in Health Related Quality Of Life
12 weeks
Patient reported Global Impression of Change
12 weeks
Study Arms (2)
Delivering Online "ZZZ's with Empirical support (DOZE) app
EXPERIMENTAL
The mobile Cognitive Behavioral Therapy for insomnia (CBTi) will be offered using the Delivering Online "ZZZ's with Empirical support (DOZE) app. Patients assigned to the intervention group will be given the DOZE app which is an integrated smart phone app and web based self-management program for adolescents and young adults with sleep problems. The intervention will be delivered on restricted password-protected application. Participants will be encouraged to log onto the sleep dairy once a day over 10-weeks to complete sleep diary, develop and track their goals, and receive sleep health education tailored sleep health interventions. After 10-weeks, participants will complete questionnaires on sleep health, pain, and Health Related Quality of Life (HQRL). The use of actigraphy will be optional in view of the COVID19 pandemic.
Other: Delivering Online "ZZZ's with Empirical support (DOZE) appOther: Sleep diary
Sleep Diary Only Attention Control
ACTIVE COMPARATOR
The control group will receive the control version of the DOZE app where the patients will be able to access the sleep diary only, without the CBTi intervention. Participants will simply use the app to input entries into their sleep diary as an attention control over a 10-week period.
After the 10-week intervention period, participants will again complete a battery of questionnaires on sleep health, pain, and HRQL. The use of actigraphy will be optional in view of the COVID19 pandemic.
Interventions
Delivering Online "ZZZ's with Empirical support (DOZE) appOther
The DOZE app is a unique digital CBTi intervention that can be used on any mobile phone, tablet or computer, using the iPhone Operating System (iOS) or Android software. It is an innovative program that consists of an integrated smart phone app and web self-management system ("DOZE") to help adolescents and young adults to sleep better. It allows data capture through entries in a sleep diary and calculation of specific clinical indices. The acquisition of baseline sleep health data over a two-week period is then used to provide personalized targets and tailored therapeutic interventions during the treatment phase. The app also includes a self-monitoring tool that fosters goal setting and provides feedback on sleep and goal attainment. DOZE allows for real time assessment of sleep related behaviors and customized reports and graphs from the young adults' data. The app provides reminders about specific goals and positive feedback (increasing scores) for each step towards a goal.
Delivering Online "ZZZ's with Empirical support (DOZE) app
Sleep diary
Eligibility Criteria
Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
You may qualify if:
Young adult patients aged 18 - 25 years old, who have
Non-malignant chronic pain lasting more than 3 months, with
Sleep Initiation and Maintenance DisordersChronic PainPain
Interventions
Amyloid
Condition Hierarchy (Ancestors)
Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms
Intervention Hierarchy (Ancestors)
Multiprotein Complexes
Study Officials
Mandeep Singh, MD
Women's College Hospital
PRINCIPAL INVESTIGATOR
Enrollment
0 participants (actual enrollment reported by the registry).
Study Design
Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Following consent, participants will be randomized and allocated to either the intervention or control arm of the trial. Randomization will be centrally controlled, and allocation will be concealed using a secure, web-based randomization on the Research Electronic Data Capture (REDCap) platform. The patients, the clinical care team (pain physicians, sleep physician, occupational therapist, and social worker), outcome adjudicators and the study statisticians will all remain blinded to randomization and group allocation. The personnel teaching the app to the intervention group will be aware of group allocation
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective pilot study with participants randomized to either the intervention Delivering Online "ZZZ's with Empirical support- DOZE app with Sleep diary/Cognitive Behavioral Therapy for insomnia- CBTi) or attention control DOZE app with Sleep diary only groups. Participants will input entries into their sleep diary as an attention control over a 10-week period. For the intervention arm, mobile CBTi will be offered using the DOZE app, an integrated smart phone app and web based self-management program. The intervention will be delivered on restricted password-protected applications that will allow adherence to be tracked. Participants will log onto the sleep dairy once a day over 10-weeks to complete sleep diary entries, develop and track their goals, and receive sleep health education tailored sleep health interventions. After 10-weeks, participants will complete questionnaires on sleep health, pain, and Health Related Quality of Life.
Actigraphy use will be optional
The control group will receive the control version of the DOZE app where the patients will be able to access the sleep diary only, without the CBTi intervention. Participants will simply use the app to input entries into their sleep diary as an attention control over a 10-week period.
Delivering Online "ZZZ's with Empirical support (DOZE) appSleep Diary Only Attention Control
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for insomnia,
English speaking with
Access to a mobile phone or a computer with internet access.
You may not qualify if:
Patients who require urgent CBT treatment as per their health care provider
Patients who have received CBT in the past 3 months
Patients participating in other psychological treatments and/or drug trials during the study
Patients who have other significant medical conditions- Life threatening (e.g. cancer), neurological conditions (e.g. epilepsy)
Patients who have other significant psychiatric conditions-Severe depression or active suicide intent
Situations resulting in forced sleep disruption or derangement of sleep schedule such as night shift work \> 2 nights per week in the past 3months, pregnancy or breastfeeding.
Inability to communicate with health care providers or the research personnel
Inability to fill out self-report questionnaires, study materials, or follow instructions.
Contact the study team to confirm eligibility.
Macromolecular Substances
Proteins
Amino Acids, Peptides, and Proteins
First Submitted
March 8, 2021
First Posted
November 30, 2021
Study Start
August 10, 2021
Actual (reported)
Primary Completion
August 10, 2021
Actual (reported)
Study Completion
August 10, 2021
Actual (reported)
Last Updated
September 20, 2024
Record last verified: 2024-09
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.